$ Value
$996K
Shares
17,001
Price
$59
Filed
Jun 17
Insider
Name
Dudum Andrew
Title
Chief Executive Officer
CIK
0001837796
Roles
Transaction Details
Transaction Date
2025-06-16
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
268,549
Footnotes
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. | The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.20 - $56.495. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.83 - $56.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.82 - $57.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.78. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.79 - $57.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.22 - $58.945. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.01 - $59.75. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | The balance represents an in-kind transfer of 186,723 Class A Common Shares to the AD 2025 GRAT dated 5-27-2025. | The balance represents an in-kind transfer of 186,723 Class A Common Shares from the Andrew Dudum 2015 Trust dated July 2, 2015. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. | The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. | Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
Filing Info
Dudum Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | HIMS | G | — |
| 2026-04-09 | HIMS | G | — |
| 2026-03-13 | HIMS | F | $10.8M |
| 2026-03-13 | HIMS | M | — |
| 2026-03-13 | HIMS | F | $2.2M |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-13 | HIMS | M | $0 |
| 2026-03-11 | HIMS | A | $0 |
Other Insiders at HIMS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Dudum Andrew
Chief Executive Officer
|
— | — | 2026-04-09 |
|
Boughton Soleil
Chief Legal Officer
|
— | $473K | 2026-04-20 |
|
Carroll Patrick Harrison
Chief Medical Officer
|
— | — | 2026-03-13 |
|
Autor Deborah M.
Chief Policy Officer
|
— | — | 2026-03-13 |
|
Becklund Irene
PAO
|
— | $137K | 2026-03-17 |
|
Okupe Oluyemi
Chief Financial Officer
|
— | $2.5M | 2026-04-20 |
|
Chi Michael
Chief Operating Officer
|
— | $2.4M | 2026-03-17 |
| Pendarvis Christiane | — | — | 2026-03-13 |
|
Elshenawy Mohamed
CTO
|
— | — | 2026-03-11 |